{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:04:54Z","timestamp":1784934294062,"version":"3.55.0"},"reference-count":24,"publisher":"Georg Thieme Verlag KG","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1055\/a-1873-4858","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T23:18:58Z","timestamp":1680131938000},"page":"467-473","source":"Crossref","is-referenced-by-count":3,"title":["Infektionen bei Patient*innen mit Akuter Myeloischer Leuk\u00e4mie"],"prefix":"10.1055","volume":"148","author":[{"given":"Sabine","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Spiekermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Hendrik","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannik","family":"Stemler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00277-017-3098-3","article-title":"Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"96","author":"WJ Heinz","year":"2017","journal-title":"Ann Hematol"},{"issue":"06","key":"ref2","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","article-title":"Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"CR Flowers","year":"2013","journal-title":"J Clin Oncol"},{"issue":"09","key":"ref3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1200\/JCO.2012.45.8109","article-title":"Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin\/clavulanic acid combination therapy--EORTC infectious diseases group trial XV","volume":"31","author":"WV Kern","year":"2013","journal-title":"J Clin Oncol"},{"issue":"16","key":"ref4","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/archinternmed.2011.374","article-title":"Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry","volume":"171","author":"L Pagano","year":"2011","journal-title":"Arch Intern Med"},{"issue":"03","key":"ref5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/10428190701809172","article-title":"Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences","volume":"49","author":"S H\u00e4m\u00e4l\u00e4inen","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"01","key":"ref6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s15010-013-0525-9","article-title":"Rolston KV. The current spectrum of infection in cancer patients with chemotherapy related neutropenia","volume":"42","author":"L Nesher","year":"2014","journal-title":"Infection"},{"issue":"12","key":"ref7","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"D Averbuch","year":"2013","journal-title":"Haematologica"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s15010-012-0269-y","article-title":"Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies","volume":"40","author":"BJ Liss","year":"2012","journal-title":"Infection"},{"issue":"S 04","key":"ref9","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1086\/427329","article-title":"Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification","volume":"40","author":"C Viscoli","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"S 07","key":"ref10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"AJ Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"S 07","key":"ref11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"OA Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"ref12","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1016\/S1473-3099(21)00203-6","article-title":"Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"21","author":"SC Chen","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"20","key":"ref13","doi-asserted-by":"publisher","first-page":"e25448","DOI":"10.1097\/MD.0000000000025448","article-title":"Comparison of invasive fungal diseases between patients with acute myeloid leukemia receiving posaconazole prophylaxis and those not receiving prophylaxis: A single-center, observational, case-control study in South Korea","volume":"100","author":"E Yang","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"07","key":"ref14","first-page":"502","article-title":"Management of invasive Aspergillosis in acute myelogenous leukemia","volume":"14","author":"BC Medeiros","year":"2016","journal-title":"Clin Adv Hematol Oncol"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"JP Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"S 07","key":"ref16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"AJ Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"OA Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"08","key":"ref18","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology","volume":"21","author":"M Hoenigl","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"08","key":"ref19","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1080\/10428194.2021.1885664","article-title":"Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality","volume":"62","author":"M Stahl","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"06","key":"ref20","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00277-021-04452-9","article-title":"Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO\/DGHO)","volume":"100","author":"AY Classen","year":"2021","journal-title":"Ann Hematol"},{"issue":"04","key":"ref21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia","volume":"356","author":"OA Cornely","year":"2007","journal-title":"N Engl J Med"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00277-017-3196-2","article-title":"Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)","volume":"97","author":"SC Mellinghoff","year":"2018","journal-title":"Ann Hematol"},{"issue":"05","key":"ref24","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/S2352-3026(22)00073-4","article-title":"Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association","volume":"9","author":"J Stemler","year":"2022","journal-title":"Lancet Haematol."},{"issue":"07","key":"ref25","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00277-020-04107-1","article-title":"Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma","volume":"99","author":"J Stemler","year":"2020","journal-title":"Ann Hematol"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1873-4858.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T23:20:14Z","timestamp":1680132014000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1873-4858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":24,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2023,3,29]]},"published-print":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1873-4858","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]}}}